Review of the Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition.
10.4166/kjg.2018.72.5.252
- Author:
Hye Kyung JUNG
1
Author Information
1. Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Korea. junghk@ewha.ac.kr
- Publication Type:Practice Guideline ; Brief Communication
- Keywords:
Evidence-based practice;
Irritable bowel syndrome;
Practice guideline
- MeSH:
Abdominal Pain;
Anti-Bacterial Agents;
Colonoscopy;
Diagnosis;
Diet;
Disaccharides;
Evidence-Based Medicine;
Evidence-Based Practice;
Irritable Bowel Syndrome*;
Korea*;
Monosaccharides;
Oligosaccharides;
Probiotics;
Quality of Life
- From:The Korean Journal of Gastroenterology
2018;72(5):252-257
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
This guidance is an updated version of the irritable bowel syndrome (IBS) guidelines based on evidence-based medicine. IBS is a common chronic gastrointestinal syndrome that occurs in approximately 10% of the population and causes chronic abdominal pain as well as bowel habit changes, such as stool frequency or consistency. The final diagnosis of IBS is based on the exclusion of organic diseases that would explain the symptoms and the absence of endoscopic abnormalities. IBS can reduce the quality of life and cause a major disease burden, such as repeated examinations and continuous drug use, by mistaking organic diseases including malignancy. The major changes are as follows: 1) when to perform a colonoscopy under the impression of IBS; 2) effect of a low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyol diet; 3) impact of probiotics in IBS; and 4) role of antibiotics in IBS. The Korean Society of Neurogastroenterology and Motility recently updated these guidelines to support physicians for qualified medical services and reduce the socioeconomic burden of IBS.
